<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="83937">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01856049</url>
  </required_header>
  <id_info>
    <org_study_id>11-007176</org_study_id>
    <nct_id>NCT01856049</nct_id>
  </id_info>
  <brief_title>Umbilical Cord Blood Collection and Processing for Cardiac Regeneration in Hypoplastic Left Heart Syndrome Patients</brief_title>
  <official_title>Umbilical Cord Blood Collection and Processing for Cardiac Regeneration in Hypoplastic Left Heart Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cell-based cardiac regeneration has been the focus of acquired, adult heart disease for many
      years. However, congenital heart disease with severe structural abnormalities may also be
      reasonable targets for cell-based therapies. Interestingly, the pediatric heart is naturally
      growing and may be the most amendable to regenerative strategies. Therefore, identifying
      autologous cells (cells from the patient's own body) would be important to initiate these
      studies.

      This study aims to validate the use of umbilical cord blood as a source of autologous cells
      for the purpose of cardiac repair of congenital heart disease. Cells will be isolated from
      the cord blood to help us determine the feasibility of collection, processing, and storage
      of these samples at the time of birth of infants with prenatal diagnosis of hypoplastic left
      heart syndrome. This study may be useful for the development of pre-clinical and clinical
      studies aimed at the long-term goal of repairing damaged heart muscle.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Percent of samples contaminated</measure>
    <time_frame>14 days after collection</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of cells that are viable following post thaw analysis</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Hypoplastic Left Heart Syndrome (HLHS)</condition>
  <arm_group>
    <arm_group_label>Umbilical Cord Blood Collection</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Collection of umbilical cord blood</intervention_name>
    <arm_group_label>Umbilical Cord Blood Collection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any pregnant woman, regardless of age, with a prenatal diagnosis of HLHS

          -  One or both parents willing to consent to the storage of umbilical cord blood for the
             specific purpose of regenerative research

          -  Mother is willing to provide a blood sample for serology testing

        Exclusion Criteria:

          -  Individuals unwilling to participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy J Nelson, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karen P Krucker, RN</last_name>
    <phone>(507) 255-4774</phone>
    <email>krucker.karen@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julia M Thebiay</last_name>
    <phone>(507) 538-8425</phone>
    <email>thebiay.julia@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Timothy T Nelson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 4, 2014</lastchanged_date>
  <firstreceived_date>May 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Timothy J. Nelson</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>HLHS</keyword>
  <keyword>Hypoplastic Left Heart Syndrome</keyword>
  <keyword>UCB (umbilical cord blood)</keyword>
  <keyword>Umbilical cord blood</keyword>
  <keyword>Cord blood</keyword>
  <keyword>Cardiac regeneration</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypoplastic Left Heart Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
